|
IPHAF
|
I read the Strategic Outlook again.
Another view - they will use the data...
|
|
IPHAF
|
The following was written in May of 2001:
"A hostile takeover isn’t...
|
|
IPHAF
|
Double edged sword dealing with large pharmas. You need them to take your...
|
|
IPHAF
|
Let me just start by saying I'm not qualified to make these statements...
|
|
IPHAF
|
March 2005 Presentation:
-carciogenic study to be over winter of 2007...
|
|
IPHAF
|
Teevee, everything I read indicates that cash flow should begin somewhere in...
|
|
IPHAF
|
Personally, I believe the company needs to be able to carry itself, which is...
|
|
IPHAF
|
May be with AST, Isotechnika could alter belatacept just slightly to reduce...
|
|
IPHAF
|
I like the JV and even the Azimuth deal.
I'm now a firm believer...
|
|
IPHAF
|
which is probably why our prize is as low as it is. Most of you know I'm...
|
|
IPHAF
|
We all wanted a piece of a drug company that would reach the market...
|
|
IPHAF
|
Like many of you, I figured Roche would be the most likely candidate to step...
|
|
IPHAF
|
Sorry fellas but this ride is difficult to hold down at times.
I'm...
|
|
IPHAF
|
The timelines have been modified a little here and there but this one is...
|
|
IPHAF
|
I don't know about you but the most important note for me was.......(you...
|
|
IPHAF
|
I like the play, if this money goes towards transplantation as indicated by...
|
|
IPHAF
|
Teevee,
Would you know how many have been recently pulled due to kidney...
|
|
IPHAF
|
A follow-up to my previous email.
Not saying much new except that things...
|
|
IPHAF
|
Interim phase III results will not be available until late 2005 as per April...
|
|
IPHAF
|
I take it your responding to Mahathir's recent statements.
What will...
|